Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

435 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The many roles of chemokines and chemokine receptors in inflammation.
Charo IF, Ransohoff RM. Charo IF, et al. Among authors: ransohoff rm. N Engl J Med. 2006 Feb 9;354(6):610-21. doi: 10.1056/NEJMra052723. N Engl J Med. 2006. PMID: 16467548 Review. No abstract available.
A dynamic spectrum of monocytes arising from the in situ reprogramming of CCR2+ monocytes at a site of sterile injury.
Dal-Secco D, Wang J, Zeng Z, Kolaczkowska E, Wong CH, Petri B, Ransohoff RM, Charo IF, Jenne CN, Kubes P. Dal-Secco D, et al. Among authors: ransohoff rm. J Exp Med. 2015 Apr 6;212(4):447-56. doi: 10.1084/jem.20141539. Epub 2015 Mar 23. J Exp Med. 2015. PMID: 25800956 Free PMC article.
A protective role for ELR+ chemokines during acute viral encephalomyelitis.
Hosking MP, Liu L, Ransohoff RM, Lane TE. Hosking MP, et al. Among authors: ransohoff rm. PLoS Pathog. 2009 Nov;5(11):e1000648. doi: 10.1371/journal.ppat.1000648. Epub 2009 Nov 6. PLoS Pathog. 2009. PMID: 19893623 Free PMC article.
Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10.
Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP. Kieseier BC, et al. Among authors: ransohoff rm. Brain. 2002 Apr;125(Pt 4):823-34. doi: 10.1093/brain/awf070. Brain. 2002. PMID: 11912115
Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?
Savarin-Vuaillat C, Ransohoff RM. Savarin-Vuaillat C, et al. Among authors: ransohoff rm. Neurotherapeutics. 2007 Oct;4(4):590-601. doi: 10.1016/j.nurt.2007.07.004. Neurotherapeutics. 2007. PMID: 17920540 Free PMC article. Review.
Chemokines and chemokine receptors in the nervous system. Rome, 24/25 October, 2009, 2nd workshop.
Trettel F, Di Angelantonio S, Limatola C, Ransohoff RM. Trettel F, et al. Among authors: ransohoff rm. J Neuroimmunol. 2010 Jul 27;224(1-2):1-7. doi: 10.1016/j.jneuroim.2010.05.001. Epub 2010 Jun 11. J Neuroimmunol. 2010. PMID: 20541268 No abstract available.
Chemokines and chemokine receptors in the nervous system Rome, 27/28 October, 2007.
Trettel F, Di Angelantonio S, Limatola C, Ransohoff RM. Trettel F, et al. Among authors: ransohoff rm. J Neuroimmunol. 2008 Jul 31;198(1-2):1-8. doi: 10.1016/j.jneuroim.2008.04.006. Epub 2008 May 29. J Neuroimmunol. 2008. PMID: 18511134 Review. No abstract available.
Natalizumab for multiple sclerosis.
Ransohoff RM. Ransohoff RM. N Engl J Med. 2007 Jun 21;356(25):2622-9. doi: 10.1056/NEJMct071462. N Engl J Med. 2007. PMID: 17582072 Review. No abstract available.
Inflammatory cortical demyelination in early multiple sclerosis.
Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, Brück W, Parisi JE, Scheithauer BW, Giannini C, Weigand SD, Mandrekar J, Ransohoff RM. Lucchinetti CF, et al. Among authors: ransohoff rm. N Engl J Med. 2011 Dec 8;365(23):2188-97. doi: 10.1056/NEJMoa1100648. N Engl J Med. 2011. PMID: 22150037 Free PMC article.
[Chemokine--possible new options for the treatment of multiple sclerosis].
Trebst C, Ransohoff RM, Windhagen A, Stangel M. Trebst C, et al. Among authors: ransohoff rm. Nervenarzt. 2003 Oct;74(10):850-7. doi: 10.1007/s00115-003-1571-9. Nervenarzt. 2003. PMID: 14551688 Review. German.
435 results
Jump to page
Feedback